1.055

2.31% -0.025

Phio Pharmaceuticals Corp (PHIO)

Overview News Price History Financials Why PHIO Down? Discussions Forecast Stock Split

Phio Pharmaceuticals Corp stock is traded at $1.055, with a volume of 79,266. It is down -2.31% in the last 24 hours and down -16.27% over the past month. Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Previous Close:

$1.08

Open:

$1.08

24h Volume:

79,266

Relative Volume:

0.03

Market Cap:

$11.30M

Revenue:

Net Income/Loss:

$-11.66M

P/E Ratio:

-0.1294

EPS:

-8.156

Net Cash Flow:

$-11.09M

1W Performance:

-4.09%

1M Performance:

-16.27%

6M Performance:

-51.38%

1Y Performance:

-45.34%

1-Day Range:

$1.045

$1.08

1-Week Range:

$1.00

$1.10

52-Week Range:

$0.9657

$9.79

Phio Pharmaceuticals Corp Stock (PHIO) Company Profile

Name

Phio Pharmaceuticals Corp

Sector

Healthcare (1130)

Industry

Biotechnology (633)

Phone

(508) 767-3861

Address

411 SWEDELAND ROAD, KING OF PRUSSIA, MA

Employee

Twitter

@phio_pharma

Next Earnings Date

2024-11-07

Latest SEC Filings

PHIO's Discussions on Twitter

Compare PHIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PHIO Phio Pharmaceuticals Corp	1.05	11.63M	0	-11.66M	-11.09M	-8.156
VRTX Vertex Pharmaceuticals Inc	459.90	117.45B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	778.21	82.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	401.28	52.92B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	843.20	52.02B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.77	37.94B	447.02M	-1.18B	-906.14M	-6.1812

Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-05-25	Resumed	H.C. Wainwright	Buy
Aug-05-20	Initiated	H.C. Wainwright	Buy

Phio Pharmaceuticals Corp Stock (PHIO) Latest News

08:30 AM

Phio Pharmaceuticals chairman Bitterman buys $5,100 in stock By Investing.com - Investing.com UK

08:30 AM

Dec 27, 2025

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - TMX Newsfile

Dec 27, 2025

Dec 24, 2025

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - TMX Newsfile

Dec 24, 2025

Phio To Commence A Toxicology Study For PH-762; Initiatives Underway For A Viable Product In 2026 - Nasdaq

Dec 24, 2025

Dec 23, 2025

Phio to begin FDA-required toxicology study for cancer drug PH-762 - Investing.com Nigeria

Dec 23, 2025

Phio Advances PH-762 With FDA-Backed Toxicology Study - TipRanks

Dec 23, 2025

Phio Pharmaceuticals Corp to begin toxicology study for PH-762 before human trialsSEC filing - marketscreener.com

Dec 23, 2025

Phio Pharmaceuticals (NASDAQ: PHIO) details FDA-cleared PH-762 tox study plan - Stock Titan

Dec 23, 2025

Phio Pharmaceuticals Corp Advances PH-762 Drug Development - TradingView — Track All Markets

Dec 23, 2025

Early PH-762 skin cancer trial sees full tumor clearance in some patients - Stock Titan

Dec 23, 2025

Dec 21, 2025

Risk Off: Why Phio Pharmaceuticals Corp. stock appeals to dividend seekersJuly 2025 Decliners & Growth Focused Stock Pick Reports - Улправда

Dec 21, 2025

Dec 20, 2025

How Phio Pharmaceuticals Corp. stock benefits from strong dollarDip Buying & Detailed Earnings Play Alerts - Улправда

Dec 20, 2025

How Phio Pharmaceuticals Corp. stock responds to policy changesWeekly Trend Recap & Reliable Intraday Trade Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Can Phio Pharmaceuticals Corp. (44R1) stock sustain breakout momentum - DonanımHaber

Dec 19, 2025

How Phio Pharmaceuticals Corp. stock reacts to Fed rate cutsJuly 2025 Macro Moves & Weekly Setup with ROI Potential - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Why Phio Pharmaceuticals Corp. stock is a value investor pick2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - Улправда

Dec 18, 2025

Why Phio Pharmaceuticals Corp. stock appeals to dividend seekersQuarterly Trade Review & Risk Managed Investment Strategies - Улправда

Dec 18, 2025

Why retail investors pile into Phio Pharmaceuticals Corp. stock2025 Earnings Impact & Daily Profit Focused Stock Screening - Улправда

Dec 18, 2025

How resilient is Phio Pharmaceuticals Corp. stock in market downturns2025 Market Sentiment & Weekly High Momentum Picks - Улправда

Dec 18, 2025

Dec 16, 2025

New Strong Buy Stocks for May 28th - MSN

Dec 16, 2025

Dec 14, 2025

MSN Money - MSN

Dec 14, 2025

Dec 12, 2025

We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run - MSN

Dec 12, 2025

Dec 09, 2025